Asthma and COVID-19

Channel:

Dr.G Bhanu Prakash Animated Medical Videos

Subscribers:

1,120,000

Published on April 7, 2020 1:58:25 PM ● Video Link: https://www.youtube.com/watch?v=Co19mb3wqpg

Duration: 3:05

49,995 views

439

📌 𝐅𝐨𝐥𝐥𝐨𝐰 𝐨𝐧 𝐈𝐧𝐬𝐭𝐚𝐠𝐫𝐚𝐦:- https://www.instagram.com/drgbhanuprakash
📌𝗝𝗼𝗶𝗻 𝗢𝘂𝗿 𝗧𝗲𝗹𝗲𝗴𝗿𝗮𝗺 𝗖𝗵𝗮𝗻𝗻𝗲𝗹 𝗛𝗲𝗿𝗲:- https://t.me/bhanuprakashdr
📌𝗦𝘂𝗯𝘀𝗰𝗿𝗶𝗯𝗲 𝗧𝗼 𝗠𝘆 𝗠𝗮𝗶𝗹𝗶𝗻𝗴 𝗟𝗶𝘀𝘁:- https://linktr.ee/DrGBhanuprakash

Asthma and COVID-19

Asthma does not appear to be a strong risk factor for acquiring COVID-19, although poorly controlled asthma may lead to a more complicated disease course for those with COVID-19.

Patients with asthma should make every effort to avoid COVID-19 exposure.

All regular medications necessary to maintain asthma control and that includes inhaled glucocorticoids, oral glucocorticoids, and biologic agents like omalizumab, be continued during the pandemic without second thoughts about immune compromise.

For patients who contract COVID-19, inhaled glucocorticoids can still be continued because there is no conclusive evidence that they have an adverse effect on the course of COVID-19.

Long-term oral glucocorticoids should also be continued, as abruptly stopping them can have a number of serious consequences causing more harm than good. Inhaled asthma medications should be given preferably to infected patients via inhalers rather than nebulizer to avoid aerosolizing SARS-CoV2 or the novel coronavirus or the COVID-19 virus thus preventing the disease spread.

For patients with asthma exacerbations, the usual guidelines should be followed for prompt initiation of systemic glucocorticoids, regardless of infection status.

#asthmaandcovid19 #covid19inasthma #covid19 #coronavirusdisease